For adults with rheumatoid arthritis (RA), there is a modest reduction in the mean Disease Activity Score in 28 joints using C-reactive protein (DAS28-CRP) at three months for patients receiving tofacitinib (TOF) versus adalimumab ...
Jul 13, 2023
0
9
Imagine taking the first sip of your morning coffee, only to be hit by an overwhelming, gut-churning stench. This altered sense of smell is a reality for many living with a post-COVID smell dysfunction called parosmia—a ...
Jul 13, 2023
0
0
As the United States faces a growing obesity epidemic, scientists are taking a closer look at how body weight can affect health outcomes. New research published in Blood Advances highlights the potential association of elevated ...
Jul 13, 2023
0
2
People dying in UK hospitals without specialist palliative care input frequently have "significant and poorly identified unmet needs," finds a UK-wide evaluation—the first of its kind—published online in the journal BMJ ...
Jul 10, 2023
0
23
There are significant variations in health care spending and care delivery across NHS hospitals in England and Wales following hip fracture, a new study aimed at understanding how hospital care impacts patients' outcomes ...
Jul 10, 2023
0
19
Breast cancer patients and survivors tend to suffer from a condition called "cancer fog"—and now a University of Southern Queensland study might have uncovered the reason why.
Jul 10, 2023
0
21
Older adults with dementia diagnosis are as likely to be registered for a patient portal as those without dementia, and they have a lower portal activity metric, according to a research letter published online June 26 in ...
Jul 7, 2023
0
2
Older patients with Alzheimer's disease and related dementia (ADRD) have almost twice the risk of dying soon after they are discharged from an intensive care unit (ICU) and within the 12 months afterward, according to research ...
Jul 3, 2023
0
2
The U.S. Food and Drug Administration has approved Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) subcutaneous injections for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine ...
Jun 28, 2023
0
2
Crisaborole is effective as a long-term maintenance therapy for pediatric and adult patients with mild-to-moderate atopic dermatitis (AD), according to a study published online May 15 in the American Journal of Clinical Dermatology.
Jun 28, 2023
0
1
